Open AccessComparing Two Strategies for Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Screening
Author(s) -
Mohammad Kabany
Publication year - 2019
Publication title -
gastroenterology pancreatology and hepatobilary disorders
Language(s) - English
Resource type - Journals
ISSN - 2641-5194
DOI - 10.31579/2641-5194/009
Subject(s) - nonalcoholic fatty liver disease , cirrhosis , liver transplantation , medicine , fatty liver , insulin resistance , disease , chronic liver disease , obesity , gastroenterology , liver disease , nonalcoholic steatohepatitis , intensive care medicine , transplantation
Nonalcoholic fatty liver disease (NAFLD) is a growing disease globally. It is strongly related to obesity and insulin resistance. NAFLD poses a public health issue because it may progress to NASH and subsequently to cirrhosis [1]. Currently, NASH cirrhosis is going to be the second most common cause for chronic liver disease in adult patients awaiting transplantation [2]. There is evidence that its prevalence is also increasing in children which creates an urgent need to identify patients with NAFLD and intervene early.